On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
All content for Brains Behind AI is the property of Ari Yacobi and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
Arturo: how AI on aerial imagery is empowering the entire value chain for the property insurance carriers
Brains Behind AI
46 minutes
4 years ago
Arturo: how AI on aerial imagery is empowering the entire value chain for the property insurance carriers
On this Episode of Brains Behind AI, Ari and Natalie had the chance to sit down and speak with John-Isaac Clark, “JC”, the CEO of Arturo. Arturo is an AI property analytics company that helps insurance carriers improve the accuracy and speed of decision making across claims, underwriting, pricing, and renewals. JC possesses more than ten years in geographical and location-based analytics with a start-up background and experience. In this episode, we learn how Suncorp, one of Australia's and N...
Brains Behind AI
On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
